News

( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the ...
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...
The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...